Otros idiomas Tasly Pharmaceutical Group Co., Ltd

Acciones

600535

CNE000001C81

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 29/04/2024			Varia. Cinco días.	Varia. 1 de enero.
15,41 ^CNY	+0,33 %		+0,78 %	-9,46 %

25/04	Tasly Pharmaceutical Group Co., Ltd informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
16/04	Tasly Pharmaceutical Group vuelve a los beneficios en 2023 mientras los ingresos de explotación se mantienen planos	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Tasly Pharmaceutical Group Returns to Profit in 2023 as Operating Income Stays Flat	16/04
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	15/04
Shanghai Yuesai Biotechnology Co., Ltd. announced that it has received CNY 100 million in funding from Tasly Pharmaceutical Group Co., Ltd, Shanghai Pudong Venture Investment Co., Ltd. and other investors	03/04
Tasly Pharmaceutical Gets Nod to Trial Stem Cell Therapy	19/01
ShuYu Civilian Pharmacy Corp., Ltd. Scraps Plan to Buy Stake in Tasly Pharmaceutical's Two Units	29/12
Pharnext : offre pour son candidat médicament dans la maladie de Charcot-Marie-Tooth de type 1A	30/10/23
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Tasly Pharmaceutical Group Co., Ltd(XSSC:600535) added to S&P Global BMI Index	18/09/23
Tasly Pharmaceutical Group Co., Ltd(XSSC:600535) added to FTSE All-World Index	18/09/23
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Les valeurs à suivre aujourd'hui à la Bourse de Paris - Vendredi 21 juillet 2023	21/07/23
Les valeurs à suivre demain à la Bourse de Paris - Vendredi 21 juillet 2023	20/07/23
Mauna Kea Technologies: chiffre d'affaires en hausse de 77% au 2e trimestre	20/07/23
Mauna Kea Technologies secures an equity line financing with Vester Finance limited to a maximum of 11.4% of the capital	01/06/23
Mauna Kea Technologies : dévisse après la mise en place d’une ligne de financement en fonds propres	01/06/23
Mauna Kea Technologies SA announced that it has received €2.3 million in funding from Tasly Pharmaceutical Group Co., Ltd	31/05/23
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23
Mauna Kea Technologies Announces Sales of EUR4.2 million for the first quarter of 2023, up 121% from 2022	21/04/23
Mauna Kea : s'envole après son chiffre d'affaires trimestriel	21/04/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Tasly Pharmaceutical Group Co., Ltd

Acciones

600535

CNE000001C81

Otros idiomas

Filtros